| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.76▲ | 0.76▲ | 0.75▲ | 0.79▼ | 0.87▼ |
| MA10 | 0.75▲ | 0.75▲ | 0.75▲ | 0.84▼ | 0.82▼ |
| MA20 | 0.75▲ | 0.75▲ | 0.76▲ | 0.89▼ | 0.88▼ |
| MA50 | 0.76▲ | 0.79▼ | 0.84▼ | 0.82▼ | 0.84▼ |
| MA100 | 0.80▼ | 0.87▼ | 0.85▼ | 0.90▼ | 0.99▼ |
| MA200 | 0.86▼ | 0.83▼ | 0.84▼ | 0.84▼ | 9.31▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.005▲ | 0.007▲ | -0.023▼ | -0.003▼ |
| RSI | 55.209▲ | 50.481▲ | 46.962▼ | 37.155▼ | 44.612▼ |
| STOCH | 73.915 | 64.660 | 58.677 | 31.158 | 69.180 |
| WILL %R | 0.000▲ | 0.000▲ | -16.231▲ | -67.510 | -63.045 |
| CCI | 81.296 | 102.272▲ | 83.481 | -118.028▼ | -32.668 |
|
Wednesday, February 11, 2026 04:00 AM
WOBURN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the commercialization and development of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/02/26 | 0.727 | 0.7673 | 0.7224 | 0.7673 | 238,871 |
| 11/02/26 | 0.832 | 0.848 | 0.73 | 0.7699 | 515,981 |
| 10/02/26 | 0.7906 | 0.80 | 0.76 | 0.78 | 298,941 |
| 09/02/26 | 0.9341 | 0.96 | 0.6505 | 0.8103 | 13,939,498 |
| 06/02/26 | 0.871 | 0.8793 | 0.8082 | 0.821 | 203,380 |
| 05/02/26 | 0.851 | 0.8697 | 0.801 | 0.8379 | 95,028 |
| 04/02/26 | 0.874 | 0.8875 | 0.84 | 0.8875 | 82,886 |
| 03/02/26 | 0.89 | 0.8911 | 0.8206 | 0.859 | 177,812 |
| 02/02/26 | 0.89 | 0.935 | 0.8301 | 0.896 | 150,997 |
| 30/01/26 | 0.98 | 0.98 | 0.93 | 0.9303 | 111,534 |
|
|
||||
|
|
||||
|
|